Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information (Tables)

v3.24.1.u1
Business Segment Information (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The financial information summarized below is presented by reportable segment for the three months ended March 31, 2024 and 2023:
2024
(in thousands) Patient Services Device Solutions
Corporate/
Eliminations
Total
 
Net revenues - external $ 18,591 $ 13,404 $ $ 31,995
Net revenues - internal 1,713 (1,713)
Total net revenues 18,591 15,117 (1,713) 31,995
Gross profit 12,274 4,200 16,474
Selling, general and administrative expenses 17,319
Interest expense (456)
Other income 3
Loss before income taxes $ (1,298)
Total assets $ 57,996 $ 44,854 $ 2,000 $ 104,850
Purchases of medical equipment $ 350 $ 1,143 $ $ 1,493
Depreciation and amortization of intangible assets $ 1,856 $ 1,044 $ $ 2,900
2023
(in thousands) Patient Services Device Solutions
Corporate/
Eliminations
Total
Net revenues - external $ 18,774 $ 11,596 $ $ 30,370
Net revenues - internal 1,630 (1,630)
Total net revenues 18,774 13,226 (1,630) 30,370
Gross profit 11,541 3,409 14,950
Selling, general and administrative expenses 15,057
Interest expense (484)
Other expense (35)
Loss before income taxes $ (626)
Total assets $ 62,769 $ 37,492 $ 2,000 $ 102,261
Purchases of medical equipment $ 2,673 $ 1,295 $ $ 3,968
Depreciation and amortization of intangible assets $ 2,178 $ 1,025 $ $ 3,203